Skip to main content
Home › Markets › Loading…
JAZZ Equity

Jazz Pharmaceuticals

NASDAQ · JAZZ

—
—
Live Price
Price History 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Jazz Pharmaceuticals (JAZZ) — Bullish & Bearish Analyst Opinions

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Jazz Pharmaceuticals (JAZZ), a cannabis-sector equity listed on NASDAQ. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: insider selling. (0 bullish signals, 1 bearish signal.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for JAZZ are maintained by Cannabis Investor News and refreshed throughout the trading day.

Data sources: SEC EDGAR, Yahoo Finance, StockAnalysis.com, and SEDAR+. Editorial signal generated by CIN's proprietary scoring model. Not investment advice.

Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.